{"nctId":"NCT02141555","briefTitle":"Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss","startDateStruct":{"date":"2014-08","type":"ACTUAL"},"conditions":["Spontaneous Abortion in First Trimester"],"count":4,"armGroups":[{"label":"Vaginal misoprostol","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Vaginal Misoprostol"]},{"label":"Buccal Misoprostol","type":"EXPERIMENTAL","interventionNames":["Drug: Buccal Misoprostol"]}],"interventions":[{"name":"Vaginal Misoprostol","otherNames":["Vaginal Cytotec"]},{"name":"Buccal Misoprostol","otherNames":["Buccal Cytotec"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Women ages 18-50 who are English or Spanish speaking\n* First trimester pregnancy (less than 13 weeks and 0 days)\n* Desires medical management of an early pregnancy loss with misoprostol\n* Diagnosed with an early pregnancy failure by UCSD Radiology or diagnosed early pregnancy failure defined by any of the following criteria (Bourne 2013):\n\n  * Crown-rump length \\> 7mm with no cardiac activity\n  * Mean gestational sac diameter of \\> 25 mm and no embryo\n  * Absence of an embryo with heartbeat \\> 2 weeks after a scan showing a gestational sac without a yolk sac\n  * Absence of embryo with heartbeat \\> 11 days after a scan showing a gestational sac with a yolk sac\n\nExclusion Criteria:\n\n* Evidence of infection, acute hemorrhage, or hemodynamic instability\n* Hemoglobin less than 9.5 including use of point of care Hgb testing\n* Known allergy to misoprostol\n* Underwent surgical or medical abortion during current pregnancy\n* Currently breastfeeding\n* Currently has intrauterine device in place\n* Suspicion of ectopic or gestational trophoblastic disease\n* History of clotting disorder or on anticoagulant therapy (excluding aspirin)\n* Unreliable for follow up","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Patient Enrollment","description":"The percentage of women who are offered enrollment and accept.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Complete Abortion","description":"Number of participants with complete abortion without surgical intervention defined as no evidence of a gestational sac on transvaginal ultrasound at the follow up visit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Answered 1 or 2 on a Scale of Satisfaction With the Procedure","description":"Written surveys patients will fill out at follow up visit assessing patient's satisfaction with the procedure.\n\n\"How satisfied were you with your procedure?\"\n\nThe satisfaction scale used was:\n\n1 =Very Satisfied, comfortable, likely to recommend 3= Neutral 5= Very unsatisfied/uncomfortable, unlike to recommend","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Reporting 2 or 3 on a Scale of Medication Side Effects","description":"Assessment of medication side effects including: nausea, vomiting, headache, fever (over 100.4 F), dizziness, diarrhea, bad taste, dry mouth \"Did you experience any of these side effects? If so, how long did they last?\"\n\nPatients asked on a scale of 0 to 3, where:\n\nSide Effect scale:\n\n0 = never\n\n1= less than one day 2 = 1 to 2 days 3 = more than 2 days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":2},"commonTop":[]}}}